M 40470
Alternative Names: M-40470Latest Information Update: 27 May 2008
At a glance
- Originator MetaPhore Pharmaceuticals
- Class Small molecules
- Mechanism of Action Superoxide dismutase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Vascular restenosis
Most Recent Events
- 02 Apr 2008 ActivBiotics sells its intellectual property assets including drug product candidates
- 02 Apr 2008 Discontinued - Preclinical for Vascular restenosis in USA
- 18 Dec 2007 Suspended - Preclinical for Vascular restenosis in USA